MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2018 International Congress

    Prevalence of non-motor symptoms in Parkinson’s disease and its impact on quality of life in a tertiary care center in India

    M. Karri, B. Ramasamy, R. Kalidoss (Coimbatore, India)

    Objective: To study the prevalence of Non-Motor Symptoms (NMS) in Parkinson’s disease (PD) and their impact on health-related quality of life (HRQoL). Background: PD is…
  • 2018 International Congress

    Study of prevalence of non-motor symptoms in typical and atypical parkinsonism as compared to age and sex matched healthy controls

    N. Barad, C. Sankhla (Mumbai, India)

    Objective: 1) To study prevalence and clinical characteristics of non-motor symptoms (NMS) in idiopathic parkinson disease (IPD) and atypical Parkinsonism (APD) as compared to age…
  • 2018 International Congress

    Selection of odorants for diagnosis of Parkinson’s disease

    O. Izhboldina, N. Zhukova, V. Alifirova, A. Latypova, I. Zhukova, .Uu. Mironova, M. Nikitina, E. Kolupaeva (Tomsk, Russia)

    Objective: The goal of this study was to identify the subset of Sniffin Sticks Test odorants that could be used to differentiate patients with Parkinson’s…
  • 2018 International Congress

    Restless legs syndrome in Parkinson’s disease patients: a comparative study on prevalence, clinical features, motor and non-motor symptoms

    S.Y. You, J.S. Lee, S.M. Jeon, Y.W. Cho (Daegu, Republic of Korea)

    Objective: We investigate the prevalence of restless legs syndrome in Parkinson’s disease patients and to identify associated clinical features, motor and non-motor symptoms. Background: Restless…
  • 2018 International Congress

    Profiles of microRNA in cerebrospinal fluid could be potential biomarkers for identifying motor subtype of Parkinson’s disease

    W. Jang (Gangneung, Republic of Korea)

    Objective: We investigated CSF miRNA expression in PD and control subjects. We also evaluated if specific miRNA were differently expressed according to motor subtype of…
  • 2018 International Congress

    Status of riding bicycle and reasons for cessation of cycling in patients with Parkinson disease: A Japanese single center cross-sectional survey

    K. Takahashi, K. Ota, K. Seo, H. Kawasaki, K. Ikeda, T. Furuya, A. Miyake, T. Mitsufuji, T. Fukuoka, Y. Ito, Y. Nakazato, N. Tamura, N. Araki, T. Yamamoto (Saitama-ken, Japan)

    Objective: To investigate the current status of riding bicycle and the reasons for cessation of cycling in patients with Parkinson disease (PD). Background: The “bicycle…
  • 2018 International Congress

    Antibodies to alpha-Synuclein in Parkinson disease

    D. Labunskiy (Santa Rosa, CA, USA)

    Objective: Alpha-synuclein (α-syn) plays a very important role in pathogenesis of Parkinson’s disease (PD). There are enough evidence of neuroinflammation in the brain tissue of…
  • 2018 International Congress

    Prevalence and associations for depression in patients with Parkinson’s disease: A Sri Lankan experience

    T. Herath, C. Rodrigo, M. Withana (Colombo, Sri Lanka)

    Objective: Estimate the prevalence of depression among patients with PD presenting to a tertiary neurology clinic in the premier healthcare institution in Sri Lanka Identify…
  • 2018 International Congress

    Prevalence of Patient-Reported Symptoms of Dysphonia and Dysphagia in Movement Disorder Patients at an Academic Medical Center

    M. Finger, M. Siddiqui, J. Tate, I. Haq, L. Madden (Winston-Salem, NC, USA)

    Objective: To determine the prevalence of patient-reported quality of life (QOL) measures of dysphonia and dysphagia in movement disorder patients at an academic medical center.…
  • 2018 International Congress

    A Phase 2 Efficacy Study of CX-8998, a Potent and Selective T-Type Calcium (Cav3) Modulator in Parkinson’s disease Tremor (PDT) Patients: Design and Dose-Selection Rationale

    S. Papapetropoulos, M. Lee, S. Boyer, M. Versavel (Cambridge, MA, USA)

    Objective: The objective of this study is to access the efficacy of CX-8998 using the MDS-UPDRS Tremor Score (MDS-UPDRS-TS) and a digital biomarker platform, while…
  • « Previous Page
  • 1
  • …
  • 239
  • 240
  • 241
  • 242
  • 243
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • #23139 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley